Nidan Laboratories and Healthcare Limited (NSE:NIDAN)
India flag India · Delayed Price · Currency is INR
12.95
-0.20 (-1.52%)
Nov 12, 2026, 3:11 PM IST

NSE:NIDAN Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
247.35255.42245.28241.77242.66296.6
Revenue Growth
-3.16%4.13%1.45%-0.36%-18.19%42.65%
Gross Profit
223.1232.62225.74219.84217.99258.9
Operating Income
26.6929.6828.2235.7837.0567.83
Net Income
11.6515.0619.77-32.3235.426.63
Earnings Per Share
0.841.081.42-2.332.552.32
EPS Growth
-22.46%-23.94%--9.76%-0.24%

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
10.419.9518.9928.584.1981.01
Total Debt
122.48111.64111.1124.35109.3192.95
Net Cash (Debt)
-112.08-91.69-92.11-95.85-25.11-111.93
Net Cash Growth
------
Net Cash Per Share
-8.09-6.60-6.63-6.90-1.81-9.76

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
22.8416.6723.655.2109.6978.28
Capital Expenditures
-11.82-4.77-9.4-7.36-6.68-70.74
Free Cash Flow
11.0111.914.247.84103.017.53
Free Cash Flow Growth
-7.48%-16.16%-70.32%-53.56%1267.61%-38.16%

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
90.20%91.07%92.04%90.93%89.83%87.29%
Operating Margin
10.79%11.62%11.50%14.80%15.27%22.87%
Pretax Margin
8.12%9.57%11.25%-9.80%19.83%15.24%
Profit Margin
4.71%5.90%8.06%-13.37%14.59%8.98%
FCF Margin
4.45%4.66%5.79%19.79%42.45%2.54%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
15.4611.7711.64-13.2917.33
P/FCF Ratio
16.3414.8916.207.864.5761.27
PS Ratio
0.730.690.941.561.941.56